Table 2 Characteristics of HCV study population
From: The high comorbidity burden of the hepatitis C virus infected population in the United States
| Â | Â | Â | Received HCV treatment during study period | |||
|---|---|---|---|---|---|---|
| Â | Total (n = 7411) | Yes (n = 3469) | No (n = 3942) | |||
| Â | n | % | n | % | n | % |
Gender | ||||||
Female | 2750 | 37.1 | 1134 | 32.7 | 1616 | 41.0 |
Male | 4661 | 62.9 | 2335 | 67.3 | 2326 | 59.0 |
Age category | ||||||
0-19 | 18 | 0.2 | 3 | 0.1 | 15 | 0.4 |
10-19 | 51 | 0.7 | 18 | 0.5 | 33 | 0.8 |
20-29 | 142 | 1.9 | 55 | 1.6 | 87 | 2.2 |
30-39 | 716 | 9.7 | 342 | 9.9 | 374 | 9.5 |
40-49 | 3194 | 43.1 | 1583 | 45.6 | 1611 | 40.9 |
50-59 | 2714 | 36.6 | 1294 | 37.3 | 1420 | 36.0 |
60-64 | 329 | 4.4 | 137 | 3.9 | 192 | 4.9 |
65+ | 247 | 3.3 | 37 | 1.1 | 210 | 5.3 |
Census Region | ||||||
Midwest | 305 | 4.1 | 142 | 4.1 | 163 | 4.1 |
Northeast | 4730 | 63.8 | 2259 | 65.1 | 2471 | 62.7 |
South | 700 | 9.4 | 368 | 10.6 | 332 | 8.4 |
West | 369 | 5.0 | 134 | 3.9 | 235 | 6.0 |
Othera | 1307 | 17.6 | 566 | 16.3 | 741 | 18.8 |
Health insurance type b | ||||||
Health Maintainance Organization | 3247 | 43.8 | 1500 | 43.2 | 1747 | 44.3 |
Individual Plans | 302 | 4.1 | 142 | 4.1 | 16. | 4.1 |
Point of Service | 755 | 10.2 | 382 | 11.0 | 373 | 9.5 |
Preferred Provider Organization | 2914 | 39.3 | 1405 | 40.5 | 1509 | 38.3 |
Other | 167 | 2.3 | 39 | 1.1 | 128 | 3.2 |
Advanced liver disease | 1462 | 19.7 | 1017 | 29.3 | 445 | 11.3 |
Cirrhosis | 1335 | 18.0 | 926 | 26.7 | 409 | 10.4 |
Hepatocellular carcinoma | 127 | 1.7 | 91 | 2.6 | 36 | 0.9 |
Drug use | 1101 | 14.9 | 447 | 12.9 | 654 | 16.6 |
Alcohol use | 485 | 6.5 | 166 | 4.8 | 319 | 8.1 |